GO:0000086 | G2/M transition of mitotic cell cycle | 3.23e-05 | 3.16e-01 | 5.431 | 3 | 5 | 97 |
GO:0000794 | condensed nuclear chromosome | 6.70e-05 | 6.55e-01 | 7.276 | 2 | 3 | 18 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.77e-04 | 1.00e+00 | 6.588 | 2 | 2 | 29 |
GO:0031100 | organ regeneration | 4.11e-04 | 1.00e+00 | 5.987 | 2 | 2 | 44 |
GO:2000615 | regulation of histone H3-K9 acetylation | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0035407 | histone H3-T11 phosphorylation | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0035402 | histone kinase activity (H3-T11 specific) | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0004151 | dihydroorotase activity | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 7.17e-04 | 1.00e+00 | 10.446 | 1 | 1 | 1 |
GO:0016363 | nuclear matrix | 1.13e-03 | 1.00e+00 | 5.256 | 2 | 7 | 73 |
GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 1 | 2 |
GO:0046602 | regulation of mitotic centrosome separation | 1.43e-03 | 1.00e+00 | 9.446 | 1 | 2 | 2 |
GO:0005654 | nucleoplasm | 1.80e-03 | 1.00e+00 | 2.671 | 4 | 55 | 876 |
GO:0005524 | ATP binding | 1.93e-03 | 1.00e+00 | 2.645 | 4 | 23 | 892 |
GO:0006543 | glutamine catabolic process | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 2.15e-03 | 1.00e+00 | 8.861 | 1 | 1 | 3 |
GO:0051414 | response to cortisol | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0000212 | meiotic spindle organization | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0001940 | male pronucleus | 2.86e-03 | 1.00e+00 | 8.446 | 1 | 1 | 4 |
GO:0014075 | response to amine | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0048096 | chromatin-mediated maintenance of transcription | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0005827 | polar microtubule | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0071313 | cellular response to caffeine | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0000930 | gamma-tubulin complex | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:0001939 | female pronucleus | 3.58e-03 | 1.00e+00 | 8.124 | 1 | 1 | 5 |
GO:2000279 | negative regulation of DNA biosynthetic process | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 6 |
GO:0006975 | DNA damage induced protein phosphorylation | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 6 |
GO:0045839 | negative regulation of mitosis | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 6 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 1 | 7 |
GO:0033762 | response to glucagon | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 1 | 7 |
GO:0000812 | Swr1 complex | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 2 | 7 |
GO:0090399 | replicative senescence | 5.01e-03 | 1.00e+00 | 7.639 | 1 | 2 | 7 |
GO:0007067 | mitotic nuclear division | 5.64e-03 | 1.00e+00 | 4.080 | 2 | 8 | 165 |
GO:0031122 | cytoplasmic microtubule organization | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 2 | 8 |
GO:0031011 | Ino80 complex | 5.72e-03 | 1.00e+00 | 7.446 | 1 | 2 | 8 |
GO:0016020 | membrane | 5.97e-03 | 1.00e+00 | 2.209 | 4 | 38 | 1207 |
GO:0005730 | nucleolus | 6.15e-03 | 1.00e+00 | 2.197 | 4 | 41 | 1217 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 2 | 9 |
GO:0008266 | poly(U) RNA binding | 6.44e-03 | 1.00e+00 | 7.276 | 1 | 1 | 9 |
GO:0006541 | glutamine metabolic process | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 10 |
GO:0043968 | histone H2A acetylation | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 2 | 10 |
GO:0007020 | microtubule nucleation | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 1 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 7.86e-03 | 1.00e+00 | 6.987 | 1 | 1 | 11 |
GO:0006281 | DNA repair | 8.43e-03 | 1.00e+00 | 3.781 | 2 | 19 | 203 |
GO:0035267 | NuA4 histone acetyltransferase complex | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 3 | 12 |
GO:0043234 | protein complex | 9.00e-03 | 1.00e+00 | 3.732 | 2 | 8 | 210 |
GO:0007095 | mitotic G2 DNA damage checkpoint | 9.28e-03 | 1.00e+00 | 6.746 | 1 | 1 | 13 |
GO:0005813 | centrosome | 9.59e-03 | 1.00e+00 | 3.684 | 2 | 8 | 217 |
GO:0043231 | intracellular membrane-bounded organelle | 9.68e-03 | 1.00e+00 | 3.678 | 2 | 7 | 218 |
GO:0004004 | ATP-dependent RNA helicase activity | 1.00e-02 | 1.00e+00 | 6.639 | 1 | 1 | 14 |
GO:0031572 | G2 DNA damage checkpoint | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 15 |
GO:0005657 | replication fork | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 2 | 16 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.21e-02 | 1.00e+00 | 6.359 | 1 | 2 | 17 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 18 |
GO:0003678 | DNA helicase activity | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 3 | 18 |
GO:0071339 | MLL1 complex | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 18 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 20 |
GO:0000077 | DNA damage checkpoint | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 1 | 21 |
GO:0017144 | drug metabolic process | 1.50e-02 | 1.00e+00 | 6.054 | 1 | 1 | 21 |
GO:0043967 | histone H4 acetylation | 1.57e-02 | 1.00e+00 | 5.987 | 1 | 2 | 22 |
GO:0003730 | mRNA 3'-UTR binding | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 1.78e-02 | 1.00e+00 | 5.802 | 1 | 2 | 25 |
GO:0000278 | mitotic cell cycle | 1.94e-02 | 1.00e+00 | 3.151 | 2 | 35 | 314 |
GO:0000781 | chromosome, telomeric region | 2.06e-02 | 1.00e+00 | 5.588 | 1 | 2 | 29 |
GO:0043195 | terminal bouton | 2.20e-02 | 1.00e+00 | 5.492 | 1 | 1 | 31 |
GO:0007595 | lactation | 2.27e-02 | 1.00e+00 | 5.446 | 1 | 2 | 32 |
GO:0042802 | identical protein binding | 2.44e-02 | 1.00e+00 | 2.978 | 2 | 7 | 354 |
GO:0005829 | cytosol | 2.45e-02 | 1.00e+00 | 1.643 | 4 | 58 | 1787 |
GO:0048146 | positive regulation of fibroblast proliferation | 2.48e-02 | 1.00e+00 | 5.317 | 1 | 1 | 35 |
GO:0005515 | protein binding | 2.53e-02 | 1.00e+00 | 1.021 | 6 | 76 | 4124 |
GO:0000226 | microtubule cytoskeleton organization | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 2 | 36 |
GO:0040008 | regulation of growth | 2.62e-02 | 1.00e+00 | 5.237 | 1 | 2 | 37 |
GO:0035690 | cellular response to drug | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 2 | 38 |
GO:0032508 | DNA duplex unwinding | 2.69e-02 | 1.00e+00 | 5.198 | 1 | 5 | 38 |
GO:0042995 | cell projection | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 2 | 41 |
GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity | 2.90e-02 | 1.00e+00 | 5.088 | 1 | 2 | 41 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.46e-02 | 1.00e+00 | 4.831 | 1 | 3 | 49 |
GO:0006310 | DNA recombination | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 6 | 50 |
GO:0006334 | nucleosome assembly | 3.60e-02 | 1.00e+00 | 4.774 | 1 | 4 | 51 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.60e-02 | 1.00e+00 | 4.774 | 1 | 5 | 51 |
GO:0005681 | spliceosomal complex | 3.88e-02 | 1.00e+00 | 4.665 | 1 | 2 | 55 |
GO:0071260 | cellular response to mechanical stimulus | 3.88e-02 | 1.00e+00 | 4.665 | 1 | 1 | 55 |
GO:0032355 | response to estradiol | 4.02e-02 | 1.00e+00 | 4.613 | 1 | 1 | 57 |
GO:0000785 | chromatin | 4.15e-02 | 1.00e+00 | 4.563 | 1 | 5 | 59 |
GO:0007265 | Ras protein signal transduction | 4.15e-02 | 1.00e+00 | 4.563 | 1 | 3 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 4.29e-02 | 1.00e+00 | 4.515 | 1 | 5 | 61 |
GO:0005634 | nucleus | 4.47e-02 | 1.00e+00 | 1.104 | 5 | 67 | 3246 |
GO:0007565 | female pregnancy | 4.50e-02 | 1.00e+00 | 4.446 | 1 | 2 | 64 |
GO:0005200 | structural constituent of cytoskeleton | 4.78e-02 | 1.00e+00 | 4.359 | 1 | 2 | 68 |
GO:0006325 | chromatin organization | 4.91e-02 | 1.00e+00 | 4.317 | 1 | 3 | 70 |
GO:0001889 | liver development | 4.98e-02 | 1.00e+00 | 4.296 | 1 | 1 | 71 |
GO:0001649 | osteoblast differentiation | 5.19e-02 | 1.00e+00 | 4.237 | 1 | 2 | 74 |
GO:0005815 | microtubule organizing center | 5.39e-02 | 1.00e+00 | 4.179 | 1 | 1 | 77 |
GO:0042127 | regulation of cell proliferation | 5.60e-02 | 1.00e+00 | 4.124 | 1 | 3 | 80 |
GO:0030529 | ribonucleoprotein complex | 5.73e-02 | 1.00e+00 | 4.088 | 1 | 4 | 82 |
GO:0006260 | DNA replication | 6.55e-02 | 1.00e+00 | 3.891 | 1 | 11 | 94 |
GO:0016887 | ATPase activity | 6.95e-02 | 1.00e+00 | 3.802 | 1 | 6 | 100 |
GO:0007507 | heart development | 7.36e-02 | 1.00e+00 | 3.718 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 7.36e-02 | 1.00e+00 | 3.718 | 1 | 2 | 106 |
GO:0000790 | nuclear chromatin | 7.56e-02 | 1.00e+00 | 3.678 | 1 | 3 | 109 |
GO:0003924 | GTPase activity | 8.23e-02 | 1.00e+00 | 3.551 | 1 | 3 | 119 |
GO:0006974 | cellular response to DNA damage stimulus | 8.36e-02 | 1.00e+00 | 3.527 | 1 | 3 | 121 |
GO:0004672 | protein kinase activity | 8.63e-02 | 1.00e+00 | 3.480 | 1 | 2 | 125 |
GO:0000398 | mRNA splicing, via spliceosome | 8.83e-02 | 1.00e+00 | 3.446 | 1 | 8 | 128 |
GO:0006184 | GTP catabolic process | 8.96e-02 | 1.00e+00 | 3.424 | 1 | 3 | 130 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 9.75e-02 | 1.00e+00 | 3.296 | 1 | 2 | 142 |
GO:0070062 | extracellular vesicular exosome | 9.77e-02 | 1.00e+00 | 1.351 | 3 | 43 | 1641 |
GO:0044822 | poly(A) RNA binding | 1.07e-01 | 1.00e+00 | 1.804 | 2 | 25 | 799 |
GO:0008380 | RNA splicing | 1.12e-01 | 1.00e+00 | 3.080 | 1 | 7 | 165 |
GO:0007283 | spermatogenesis | 1.14e-01 | 1.00e+00 | 3.054 | 1 | 2 | 168 |
GO:0043025 | neuronal cell body | 1.16e-01 | 1.00e+00 | 3.028 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 1.20e-01 | 1.00e+00 | 2.987 | 1 | 6 | 176 |
GO:0004674 | protein serine/threonine kinase activity | 1.33e-01 | 1.00e+00 | 2.824 | 1 | 2 | 197 |
GO:0005525 | GTP binding | 1.33e-01 | 1.00e+00 | 2.824 | 1 | 5 | 197 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 1.37e-01 | 1.00e+00 | 2.781 | 1 | 1 | 203 |
GO:0019899 | enzyme binding | 1.41e-01 | 1.00e+00 | 2.732 | 1 | 4 | 210 |
GO:0006200 | ATP catabolic process | 1.47e-01 | 1.00e+00 | 2.671 | 1 | 8 | 219 |
GO:0019901 | protein kinase binding | 1.55e-01 | 1.00e+00 | 2.588 | 1 | 11 | 232 |
GO:0003723 | RNA binding | 1.64e-01 | 1.00e+00 | 2.498 | 1 | 11 | 247 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.41e-01 | 1.00e+00 | 1.888 | 1 | 10 | 377 |
GO:0005794 | Golgi apparatus | 2.62e-01 | 1.00e+00 | 1.749 | 1 | 5 | 415 |
GO:0005737 | cytoplasm | 2.85e-01 | 1.00e+00 | 0.669 | 3 | 50 | 2633 |
GO:0010467 | gene expression | 3.26e-01 | 1.00e+00 | 1.383 | 1 | 31 | 535 |
GO:0005615 | extracellular space | 3.83e-01 | 1.00e+00 | 1.100 | 1 | 8 | 651 |
GO:0008270 | zinc ion binding | 4.18e-01 | 1.00e+00 | 0.940 | 1 | 7 | 727 |
GO:0044281 | small molecule metabolic process | 4.69e-01 | 1.00e+00 | 0.725 | 1 | 32 | 844 |
GO:0006351 | transcription, DNA-templated | 5.58e-01 | 1.00e+00 | 0.375 | 1 | 9 | 1076 |